EUVIMEDEUVIMED entdecken
Fallbericht

A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritis

Yuki Imai iD, Yasushi Kondo, Sho Ishigaki, Naoshi Nishina, Yuichiro Ota, Hironari Hanaoka, Yuko Kaneko, Tsutomu Takeuchi

Modern Rheumatology Case Reports · 07.01.2022 · 6 (1) · 83-86

DOI: 10.1093/mrcr/rxab010 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, online erschienen am 11.08.2021. Verfasst von Yuki Imai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Churg-Strauss Syndrome, Eosinophilia, Granulomatosis with Polyangiitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An 83-year-old woman with a history of asthma complained of left abdominal pain and was admitted to our hospital. She was treated with tocilizumab, an anti-interleukin (IL)-6 receptor antibody, with a prolonged interval for rheumatoid arthritis (RA). Laboratory tests revealed a remarkable increase in eosinophil count and inflammatory markers with negative antineutrophil cytoplasmic antibodies. Echocardiography revealed pericardial fluid retention, and contrast-enhanced computed tomography revealed the thickening of the gastric antrum wall. Upper gastrointestinal endoscopy and biopsy revealed eosinophilic infiltration into the gastric mucosal epithelium. She was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA) with pericarditis and eosinophilic gastroenteritis. High-dose glucocorticoids with intermittent intravenous cyclophosphamide (IVCY) were initiated, resulting in remission. As IL-6 is involved in the pathogenesis of allergic diseases such as asthma, our case can provide insights into the pathogenic role of IL-6 in EGPA as the development of EGPA in our case may have been triggered by IL-6 signals enhanced with tocilizumab interval prolongation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidChurg-Strauss SyndromeEosinophiliaGranulomatosis with PolyangiitisAged, 80 and overAntibodies, Antineutrophil CytoplasmicFemaleHumans

Stichwörter der Autor:innen

ANCA-associated vasculitisEosinophilic granulomatosis with polyangiitisinterleukin-6rheumatoid arthritistocilizumab

Substanzen

Antibodies, Antineutrophil Cytoplasmic

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

ORCID-Profile: Yuki Imai

Zitieren

APA

Imai, Y., Kondo, Y., Ishigaki, S., Nishina, N., Ota, Y., Hanaoka, H., Kaneko, Y., & Takeuchi, T. (2022). A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritis. Modern Rheumatology Case Reports, 6(1), 83-86. https://doi.org/10.1093/mrcr/rxab010

Vancouver

Imai Y, Kondo Y, Ishigaki S, Nishina N, Ota Y, Hanaoka H, et al. A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritis. Modern Rheumatology Case Reports. 2022;6(1):83-86. doi:10.1093/mrcr/rxab010

BibTeX
@article{Imai2022,
  author = {Imai, Yuki and Kondo, Yasushi and Ishigaki, Sho and Nishina, Naoshi and Ota, Yuichiro and Hanaoka, Hironari and Kaneko, Yuko and Takeuchi, Tsutomu},
  title = {A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritis},
  journal = {Modern Rheumatology Case Reports},
  year = {2022},
  volume = {6},
  number = {1},
  pages = {83--86},
  doi = {10.1093/mrcr/rxab010}
}
Kostenlos starten →